Protocol Ledger

NCT04456998 · Phase II · COMPLETED

GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

Interventional Phase II clinical trial protocol NCT04456998 sponsored by GB002, Inc., a wholly owned subsidiary of Gossamer Bio in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-11-12 Enrollment: 86 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04456998
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)86 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04456998
Protocol FieldVerified Registry Value
NCT IdentifierNCT04456998
Consolidated Lead SponsorGB002, Inc., a wholly owned subsidiary of Gossamer Bio
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment86 participants (ACTUAL)
Registered Start Date2020-11-12
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI